Bertin Pharma is acquired by Bertin Technologies on January 2018. The Bioreagent activity is now included into the Business Unit Systems & Instrumentation. Bertin Technologies
On August 2017, Bertin Pharma has signed an agreement for the sale of its pre-clinical and clinical studies’ activities. Bertin Pharma decided to focus on
Genetics alone don’t account for a patient’s age, history of diseases, personal habits or environmental exposure. In order to take into account these factors without
Not on holidays yet? Lucky you…. You deserve your FREE Anti-Stress! Dive into the summertime… Summer holidays are around the corner…patience! In the meanwhile, we
Meet us there: 21-23 June in Berlin, Germany! Let’s share in great depth about one of the main causes of DNA damage, the Oxidative Stress.
Peter Reeh – Farewell Symposium “New Aims and Targets in Nociception”, 15-16 June – Erlangen (Germany) They have been using our Assay Kits for many
Open-Label Placebos: “I knew they were sugar pills but I felt fantastic” May 2017: A review of five studies, involving 260 patients found that placebos are
Have you tried our must-have yet? Here is a selection of some of our best Chemokines tools for your research: If you any other information,
New article on Inflammation Research: Here is a fascinating article on how searchers from Munich pinpoints potential targets for new therapies by leading systematic analysis
Pig is used as a model in metabolic disorders due to its metabolism closely related to human but more recently as an alternative to canine
The Easter Hunt is open… …and Bunny is hiding on our website! You think you can find him? Let’s play a little game then… Find
Get 20% OFF any products from our partner TargetMol! Hurry up this offer will lasts til April 30th!
